Cis (1S,3R)-1-(9-adenyl)-3-hydroxycyclopentane inhibits the respiratory burst from polymorphonuclear leukocytes and has in vivo efficacy in an acute and chronic model of inflammation

Nucleosides and Nucleotides

Volumn 15, Issue 5, 1996, Pages 967-979

  Borcherding, David R ^a   Butler, Brent T ^a   Linnik, Matthew D ^a   Mehdi, Shujaath ^a   Dudley, Mark W ^a   Edwards III, Carl K ^a  

^a Merrell Dow Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (3 HYDROXYCYCLOPENTYL)ADENINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; NUCLEOSIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CHIRALITY; CHROMATOGRAPHY; DISEASE MODEL; IMMUNIZATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; NONHUMAN; PHAGOCYTOSIS; RESPIRATORY BURST; RHEUMATOID ARTHRITIS;

EID: 0029877971     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319608002028     Document Type: Article

References (38)

1. Johnston, R.B.; Godzik, C.A.; Cohn, Z.A. J. Exp. Med. 1978,148,115.
2. Adams, D.O.; Hamilton, T.H. Ann. Rev. Immunol. 1984,2,283.
3. Edwards, III, C.K.; Ghiasuddin, S.M.; Schyzer, J.M.; Yunger, L.M.; Kelley, K.W. Science 1988,239,769.
4. Cronstein, B.N.; Hirschhorn, R. Adenosine and Adenosine Receptors, Williams, M., Ed; The Humana Press: Clifton, New Jersey, 1990; pp475-485.
5. Aida, Y.; Pabst, M.J. J. Immunol. 1990,145,3017.
6. Fu, Y.-K.; Arkins, S.; Wang, B.S.; Kelley, K.W. J. Immunol. 1991,146,1602.
7. Nathan, C.F. Mechanisms of host resistance to infectious agents, tumors and allografts. Sturman, R.M., North, R.J., Eds.; Rockefeller University Press: New York, 1986: pp.165-184.
8. Dinauer, M.C.; Ezekowitz, R.A.B. Curr. Opin. Rheum. 1991,3,61.
9. Clark, I.A.; Thumwood, C.M.; Chaudhri, W.B.; Hunt, N.H.; Oxygen Radicals and Tissue Injury. Halliwell, B., Ed., FASEB J. Press: Baltimore, MD, 1987: pp.122-129.
10. Wordsworth, P. Curr. Opin. Rheum. 1990,2,423.
11. Breedweld, F.C.; De Vries, R.R.P. Clin. Rheum. 1990,9,171.
12. Norcombe, H.L.; Backnall, R.C.; Edwards, S.W. In Vivo. Brit. J. Rheum. 1990,50,147.
13. Cronstein, B.N.; Kromer, S.B.; Weisman, G.; Hirschhorn, R. Exp. Med. 1983,158,1160.
14. De la Harpe, J.; Nathan, C.F. J. Immunol. 1989,143,596.
15. a. Cronstein, B.N.; Levin, R.I., Prubyer, M.; Hirschhorn, R.; Abramson, S.B.; Weismann, G. J. Immunol. 1992,148,2201;
16. b. Edwards,III, C.K.; Watts, L.M.; Parmely, M.J.; Linnik, M.D.; Lay, R.E.; Borcherding, D.B.J. Leuk. Biol. In press.
17. Theil, F.; Schick, H,; Weichert, D.; Tannenberger, K.; Klappach, G. Liebigs Ann. Chem. 1991,195.
18. 3) 6.2(m, 1H), 6.1 (m, 1H), 5.9 (s, 1H), 5.1 (m, 1H), 2.59 (ddd, 1H, J= 15.2, 6.9, 2.9 Hz), 2.37 (ddd, 1H, J = 15.2, 6.9, 2.9 Hz), 2.37 (s, 3H). Personal cummunication from Dr. Tim Curran and David Hay; Oppolzer, W.; Gaudin, J.-M.; Birkinshaw, T.N. Tetrahedron Lett. 1988,29,4705; Seagebrath, K.A., J. Am. Chem. Soc. 1960,25,2212; Owen, L.N.; Smith, P.N., J Chem. Soc. 1952,4035.
19. 3) 6.2(m, 1H), 6.1 (m, 1H), 5.9 (s, 1H), 5.1 (m, 1H), 2.59 (ddd, 1H, J= 15.2, 6.9, 2.9 Hz), 2.37 (ddd, 1H, J = 15.2, 6.9, 2.9 Hz), 2.37 (s, 3H). Personal cummunication from Dr. Tim Curran and David Hay; Oppolzer, W.; Gaudin, J.-M.; Birkinshaw, T.N. Tetrahedron Lett. 1988,29,4705; Seagebrath, K.A., J. Am. Chem. Soc. 1960,25,2212; Owen, L.N.; Smith, P.N., J Chem. Soc. 1952,4035.
20. 3) 6.2(m, 1H), 6.1 (m, 1H), 5.9 (s, 1H), 5.1 (m, 1H), 2.59 (ddd, 1H, J= 15.2, 6.9, 2.9 Hz), 2.37 (ddd, 1H, J = 15.2, 6.9, 2.9 Hz), 2.37 (s, 3H). Personal cummunication from Dr. Tim Curran and David Hay; Oppolzer, W.; Gaudin, J.-M.; Birkinshaw, T.N. Tetrahedron Lett. 1988,29,4705; Seagebrath, K.A., J. Am. Chem. Soc. 1960,25,2212; Owen, L.N.; Smith, P.N., J Chem. Soc. 1952,4035.
21. a.)Da Silva, A.D.; Coimbra, E.S.; Fiurrey, J.L.; Machado, A.S.; Robert-Gero, M. Tetrahedron Lett. 1993,34,6745:
22. b.) Koga, M; Schneller, S.W. J. Org. Chem. 1993,58,6471;
23. c.) Merlo, V.; Reece, F.J.; Roberts, S.M.; Gregson, M.; Storer, R. J. Chem. Soc., Perkin Trans 1 1993, 1717.
24. Davila, D.R.; Edwards III, C.K.; Arkins; S. Simon, J.; Kelley, K.W. FASEB J. 1990,4,2906.
25. Hambleton, P.; Miller, P. Agents Action 1989,28,73.
26. Esser, R.E.; Eyerman, M.C.; Port, C.D.; Anderson, W. Int. J. Tissue Reactivity 1989,11,291.
27. Diliberto, E.J. Jr. Cellular Regulation of Secretion and Release, Conn, P.M., Ed. Academic Press: New York, 1982: pp 147-192.
28. Mehdi, S.; Jarvi, E.T.; Koehl, J.R.; McCarthy, J.R.; Bey, P., Enzyme Inhibition 1990,4,1.
29. Jarvis, M.F.; Schulz, R.; Hutchison, A.J.; Do, U.H.; Sills, M.A.; Williams, M. J. Pharmacol. Exp. Ther. 1989,251,888.
30. Goodman, R.; Cooper, M.; Gavish, M.; Synder, S. Mol. Pharmacol. 1982,21,329.
31. Parmely, M.J.; Zhou, W-W.; Edwards, C.K.,III; Borcherding, D.R.; Silverstein, R.; Morrison, D.C., J. Immun. 1993,151,389.
32. b. Bradshaw, M.; Rutherford, M.S.; Hoeper, B.J.; McWhinney, C.D.; Borcherding, D.R.; Schook, L.B.; Edwards III, C.K. J. Pharmacol. Exper. Therap. 1995,273,1506.
33. Berkow, R.L.; Dodson, M.R. J. Leuk. Biol. 1988,44,345.
34. Berkow, R.L.; Wang, D.; Larrick, J.W.; Dolson, R.W. Immunol. 1987,139,3783.
35. Cronstein, B.N.; Weissmann, G. Arthritis Rheum. 1993,36,147.
36. a.) Hunneyball, I.M.; Crossley, M.J.; Spowage, M. Agents Actions 1986,18,384;
37. b.) De, M.; Baker, T.J.; Mountz, J.D.; Edwards, C.K. Arthritis Rheum. 1992,35,S140.
38. McWhinney, C.D., Dudley, M.W., Bowlin, T.L., Peet, N.P., Schook, L., Bradshaw, M., De, M., Borcherding, D.R., Edwards, III., C.K. J. Biol. Chem. submitted.